April 22, 2017 by Greg Jacobson and Chain Drug Review
CVS Health, Larry Merlo, Thomas Moriarty
2017, Issue 04-24-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has appointed Thomas Moriarty to the new position of chief policy and external affairs officer. He had been executive vice president, general counsel and chief strategy officer. In addition, CVS has consolidated corporate communications, legal, government affairs and public policy into one operating unit under Moriarty, who continues to report
April 22, 2017 by Chain Drug Review
Allscripts, CVS Health, DeAnn Mullins, e-prescription, e-prescription monitoring system, electronic prescribing, Jay Bhattacharyya, National Community Pharmacists Association, Sentinel, Surescripts, Tom Skelton, Troyen Brennan
Pharmacy, Supplier News, Technology
ARLINGTON, Va. — Surescripts aims to sharpen the accuracy of electronic prescribing with the launch of its new Sentinel automated e-prescription monitoring system. Announced this week, Sentinel will boost patient safety, care quality and workflow efficiency by pinpointing areas for improvement and analyzing e-prescribing trends for better patient care, the health information network said. Sentinel
April 22, 2017 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, Larry Merlo, Medicaid reimbursements, National Association of Chain Drug Stores, National Community Pharmacists Association, Tom Moriarty
2017, Issue 04-24-2017, Issues, Opinion
CVS Health earlier this month named Tom Moriarty to the new position of chief policy and external affairs officer. As explained by president and chief executive officer Larry Merlo, the rationale behind the creation of the role is to “deliver an integrated approach to policy development and external engagement so the company can contribute to
April 20, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, Helena Foulkes, Judy Sansone, Morgan Diaz, slideshow
Featured Articles, Leading Headlines, Retail News, Slideshows
NEW YORK — As shown by the evolution of its front-end strategy, CVS didn’t change its name to CVS Health and remove tobacco products from its stores more than two years ago for nothing. Executives at the interactive brand showcase CVS held Wednesday in Manhattan noted that health and well-being underpins virtually all facets of
April 19, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, Helena Foulkes, Judy Sansone, K-Beauty HQ, Korean beauty
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Pharmacy has unveiled the next phase of its front-end strategy, including new store designs, more better-for-you food and health-focused products, expanded beauty offerings and informational signage storewide. CVS said more than 800 stores nationwide have been remodeled with the new front-end design and assortment, and over 3,400 locations now have expanded
April 18, 2017 by Chain Drug Review
Baligh Yehia, CVS Health, CVS MinuteClinic, David McIntyre, Department of Veterans Affairs, John McCain, Maureen McCarthy, MinuteClinic, Phoenix VA Health Care System, Tobias Barker, TriWest Healthcare Alliance
Featured Articles, Leading Headlines, Pharmacy, Retail News
PHOENIX — CVS Health’s MinuteClinic is taking part in a public-private alliance to expand access to health care services for veterans in the Phoenix area. Under an initiative by the Department of Veterans Affairs (VA), the Phoenix VA Health Care System (HCS), the TriWest Healthcare Alliance and CVS MinuteClinic, nearly 120,000 veterans enrolled in the
April 10, 2017 by Chain Drug Review
Billion Dollar Roundtable, CVS Health, Eva Boratto, supplier diversity
Business, Retail News
WOONSOCKET, R.I. — CVS Health has been recognized by Billion Dollar Roundtable for reaching its goal of spending more than $1 billion with diverse suppliers. With the honor, CVS Health joins the ranks as one of 26 major U.S.-based corporations that provide thought leadership and solutions-driven exploration of key issues in supplier diversity. “We are
April 6, 2017 by Chain Drug Review
CVS Health, Larry Merlo, Thomas Moriarty
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health has named Thomas Moriarty as chief policy and external affairs officer, a newly created position. CVS said Thursday that Moriarty, who has served as executive vice president and general counsel, will bring corporate communications, legal, government affairs and public policy under a single operating unit to manage the company’s external
April 4, 2017 by Chain Drug Review
Advanced Care Scripts, Alan Lotvin, CVS Health, Kylanne Green, specialty medications, specialty pharmacy, URAC, URAC-accredited specialty pharmacy
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health’s Advanced Care Scripts (ACS) has gained specialty pharmacy accreditation from Washington, D.C.-based health care standards body URAC. CVS said Tuesday that the URAC designation signifies that its ACS unit has demonstrated a commitment to quality care, improved processes and better patient outcomes. ACS manages and dispenses specialty medications to patients
April 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Blue Cross and Blue Shield Federal Employee Program, CVS Health, Prime Therapeutics, Walgreens
Business, Pharmacy, Retail News
NEW YORK — Next year, the specialty pharmacy services contract for the Blue Cross and Blue Shield Federal Employee Program (FEP) is slated to pass from CVS Health to Prime Therapeutics LLC. CVS said its specialty pharmacy contract with BCBS FEP will terminate at the end of 2017. Under separate agreements that run through 2018,
April 3, 2017 by Chain Drug Review
CVS Caremark, CVS Health, Doug Langa, Jon Roberts, Novo Nordisk, prescription savings program, Reduced Rx, Troy Brennan
2017, Issue 04-03-2017, Issues, News
WOONSOCKET, R.I. — CVS Health last month announced the launch of Reduced Rx, a prescription savings program offering discounts on certain medications directly to patients through the company’s pharmacy benefits manager, CVS Caremark. The announcement came a day after the company reported that prescription growth for CVS Caremark clients slowed in 2016 to its lowest
April 3, 2017 by David Pinto and Chain Drug Review
chain drug retailing, chain drug stores, CVS Health, David Pinto, mass retailing industry, pharmacy retailers, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid deal
2017, Issue 04-03-2017, Issues, Opinion
April is here — and still no resolution on the pending acquisition of Rite Aid Corp. by Walgreens Boots Alliance Inc. As time stretches out, this indecision bodes ill for an acquisition that was until recently viewed as an agreement with benefits for both parties. Now, confusion is apparently overtaking certainty — and there is
March 16, 2017 by Chain Drug Review
CVS Caremark, CVS Health, Doug Langa, Jon Roberts, Novo Nordisk, prescription drug savings program, Reduced Rx, Troy Brennan
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health plans to serve up discounts on certain medications via a new prescription drug savings program called Reduced Rx. CVS said Thursday that Reduced Rx is designed to help patients with high out-of-pocket costs afford vital medications. The discounts will be offered directly to patients through CVS Caremark, the company’s pharmacy benefit
March 15, 2017 by Chain Drug Review
CVS Caremark, CVS Caremark drug trend, CVS Health, prescription drug prices, Troyen Brennan
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health said it was able to counteract rising prescription drug prices for its pharmacy benefit management clients in 2016, achieving their lowest drug trend in the past four years. CVS said Wednesday that CVS Caremark clients saw their prescription drug trend fall to an average of 3.2% last year versus 5%